Insights and Analysis
AI-washing – when AI hype becomes a litigation risk
Insights and Analysis
Proactive and forward-looking disclosure risks for pharma
22 January 2026
Jennifer Windom and Bolton Smith present the risks and considerations pharmaceutical and life sciences companies have to take when making proactive and forward-looking disclosure statements.
Read the full article here.
This article is published by Drug Discovery World.
Contacts
Articles you may be interested in
View more insights and analysis
